Jørgen E. Nielsen

Transthyretin as a potential CSF biomarker for Alzheimer’s disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors

C. Nilsson, B. B. Andersen, J. Nielsen, 2010, European journal of neurology.

Alzheimer disease‐like clinical phenotype in a family with FTDP‐17 caused by a MAPT R406W mutation

J. Stokholm, S. Lindquist, M. Batbayli, 2008, European journal of neurology.